Trial Profile
Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra) in Healthy Subjects Aged 9 Months to 55 Years in Vietnam
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Mar 2019
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections; Meningococcal meningitis
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 05 Mar 2019 Results evaluating safety of a quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine published in the Pharmacoepidemiology and Drug Safety
- 10 Oct 2017 Status changed from recruiting to completed.
- 07 Jun 2016 Planned End Date changed from 1 Feb 2017 to 1 Dec 2017.